| Literature DB >> 32082003 |
Michael Josef Kridanto Kamadjaja1, Janery Fidelia Abraham2, Harry Laksono1.
Abstract
INTRODUCTION: Crab shell (Portunus pelagicus) has the potential to be a source of hydroxyapatite biomaterials that used as bone grafts. Before clinical application, crab shell graft should be tested for its biocompatibility in vitro on human gingival fibroblast. AIM: This study aimed to determine the biocompatibility of Portunus pelagicus hydroxyapatite graft on human gingival fibroblast cell culture.Entities:
Keywords: Fibroblasts; Graft; Hydroxyapatites
Mesh:
Substances:
Year: 2019 PMID: 32082003 PMCID: PMC7007623 DOI: 10.5455/medarh.2019.73.378-381
Source DB: PubMed Journal: Med Arch ISSN: 0350-199X
Figure 1.SEM micrograph of hydroxyapatite crab shell samples at 500x magnification from two different fields of view
Figure 2.EDX spectrum of hydroxyapatite samples from Portunus pelagicus with three main elements, O, Ca, and P.
Calculation of normalized weight and calculation of atoms in Hydroxyapatite Graft derived from Portunus pelagicus.
| Element | Normalized Weight Calculation (wt.%) | Atom Calculation (at.%) | Standard deviation |
|---|---|---|---|
| O | 67,59 | 83,54 | 6,9 |
| Ca | 29,16 | 14,39 | 0,7 |
| P | 3,25 | 2,08 | 0,1 |
The mean value of optical density and the percentage of living cells for each treatment.
| Treatment Group | N | Optical Density Mean | Standard Deviation | Percentage of Living Cells |
|---|---|---|---|---|
| Hydroxyapatite graft 100ppm | 5 | 0,0684 | 0,017785 | 89,8% |
| Hydroxyapatite graft 50ppm | 5 | 0,0724 | 0,018366 | 93,27% |
| Hydroxyapatite graft 25ppm | 5 | 0,0816 | 0,018366 | 101,2% |
| Cell Control | 5 | 0,0802 | 0,014704 | 100% |
| Media Control | 5 | 0,0358 | 0,000837 | 0% |